Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
PRP2117 Mouse IL-4 protein (Animal-Free) Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage Polarization(PRP2117-7.666) 7.666 Cells
PRP100398 Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage Polarization(PRP100398-7.666) 7.666 Cells
ABT2024 Magnetic Beads Conjugated Anti-GFP Tag Mouse Monoclonal Antibody (3D3) Histone deacetylase CsHDA6 mediates the regulated formation of the anti-insect metabolite α-farnesene in tea (Camellia sinensis)(ABT2024-5.363) 5.363 Plant Science
KTA2011 One-step TUNEL Apoptosis Assay Kit (Orange Fluorescence) MicroRNA-196a-3p modulates neural stem cell proliferation against cerebral ischemia/reperfusion injury by ARF4 signaling(KTA2011-/) / Authorea Preprints
KTA2030 EdU Cell Proliferation Image Kit (Green Fluorescence) MicroRNA-196a-3p modulates neural stem cell proliferation against cerebral ischemia/reperfusion injury by ARF4 signaling(KTA2030-/) / Authorea Preprints
A23240 Dylight 488, Goat Anti-Rat IgG Electroacupuncture reduces blood glucose by regulating intestinal flora in type 2 diabetic mice(A23240-4.53) 4.53 Journal of Diabetes
A23420 Dylight 594, Goat Anti-Rabbit IgG Electroacupuncture reduces blood glucose by regulating intestinal flora in type 2 diabetic mice(A23420-4.53) 4.53 Journal of Diabetes
A21020 HRP, Goat Anti-Rabbit IgG Lysine 222 in PPAR γ1 functions as the key site of MuRF2-mediated ubiquitination modification(A21020-/) / Authorea Preprints
KTA0002 Annexin V-AbFluor™ 488/PI Apoptosis Detection kit Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer(KTA0002-5.062) 5.062 Journal of Drug Delivery Science and Technology
A21020 HRP, Goat Anti-Rabbit IgG Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer(A21020-5.062) 5.062 Journal of Drug Delivery Science and Technology